近年来，中国人民银行凉山州分行结合凉山州委、州政府打造生物医药产业集群的战略部署，推动金融 资源精准流入重点环节和龙头企业。通过差异化信贷支持、集群式产融协同和创新型金融产品，凉山生 物医药产业加速崛起，为地方经济注入新动能。 围绕生物医药企业不同发展阶段和经营特点，当地金融机构提供差异化信贷支持，精准满足企业从种植 收购、经营周转到基地建设、智能制造等各环节的融资需求。截至目前，全州银行机构已为生物医药企 业提供授信超7.36亿元，发放贷款5.98亿元，贷款加权平均利率仅3.53%，显著低于全州平均水平。工 行凉山分行以信用方式为好医生攀西药业发放流动资金贷款1亿元，利率低至2.42%，有效缓解了企业 的资金压力。 在四川省凉山州西昌生物医药产业园，好医生、新鑫中药、华润三九（000999）等龙头企业正加紧生 产。车间里，自动化设备高速运转，科研人员正进行检测。"这几年金融支持越来越有力，资金能覆盖 种植、加工、研发等环节，让企业敢投入、能扩产。"好医生攀西药业相关负责人对《金融时报》记者 说。 针对生物医药企业轻资产、高研发的特点，中国人民银行凉山州分行鼓励银行创新贷款模式，推广知识 产权质押、科研项目贷 ...

Group 1 - The Tsinghua University initiative "Liangshan Journey" was launched on August 4, with 43 outstanding teachers and students participating in social practice in Liangshan [1] - Participants visited Haoyisheng Panxi Pharmaceutical to understand its production and operational status, highlighting Liangshan's unique resource advantages and the development of traditional Chinese medicine [5][6] - Haoyisheng's product, Kangfu New Liquid, achieved over 1 billion yuan in annual sales and became the first traditional Chinese medicine to receive certification from Health Canada, showcasing the internationalization of Chinese medicine [8] Group 2 - The company integrates traditional Chinese medicine with modern technology, establishing research platforms and collaborating with multiple universities to drive innovation [6][9] - The digital and intelligent breeding of American cockroaches is showcased, with 22 billion cockroaches being raised in a controlled environment to ensure safety and stability of raw materials [9] - The digitalized production line for Kangfu New Liquid employs smart systems for precise control, enhancing production capacity and quality, contributing to the high-quality development of Liangshan's pharmaceutical industry [9]

Core Viewpoint - The recognition of "Good Doctor Pharmaceutical Manufacturing Intelligent Factory" as an advanced intelligent factory by Sichuan Province marks a significant achievement in the digital transformation and intelligent manufacturing level of the company [1]. Group 1: Intelligent Factory Development - The intelligent factory project was initiated in 2020 with a total investment exceeding 800 million yuan, and it is expected to be fully operational by 2024 [3]. - The factory incorporates over 450 advanced equipment sets, achieving full automation in material transportation, packaging, and stacking processes [3]. - The production line automation rate reaches 98%, resulting in improved production efficiency, reduced energy consumption, and decreased quality deviations [3]. Group 2: Biological Raw Material Management - The intelligent factory signifies a new phase in the large-scale breeding of medicinal American cockroaches, with 22 billion cockroaches raised under a patented feed formula and simulated ecological conditions [6]. - Parameters such as temperature, humidity, light, and bacterial counts are precisely controlled through a digital system to ensure the safety and stability of raw materials [6]. - The seamless integration of biological breeding and formulation filling enhances the production of the core product, "Good Doctor Recovery Liquid" [6]. Group 3: Research and Development Investment - The company has established national-level research platforms, including a postdoctoral research workstation and a key laboratory for American cockroaches and innovative drugs, supporting the R&D of traditional Chinese medicine [7]. - Currently, the company is undertaking over 70 major national and provincial research projects, with its core product being the first traditional Chinese medicine approved for market in Canada [7]. - The project not only enhances the company's digital and intelligent capabilities but also promotes the development of related industries and creates local employment opportunities [7]. Group 4: Future Outlook - The company aims to leverage its recognition as an advanced intelligent factory to deepen intelligent applications and build a digital ecosystem covering the entire industry chain from breeding to production, R&D, and sales [7]. - There is a focus on exploring the integration of traditional Chinese medicine with artificial intelligence and big data, aiming to rejuvenate traditional practices in the digital age [7].

Group 1 - The 20th China Western International Expo (West Expo) was held in Chengdu, Sichuan, from May 5 to May 29, with over 3,000 domestic and international enterprises participating [1] - The West Expo has developed into a significant platform for promoting the development of Western China and international cooperation over 25 years, showcasing breakthroughs in cutting-edge fields such as artificial intelligence, biotechnology, new displays, and low-altitude economy [3] - Good Doctor Group showcased its products, including Good Doctor Rehabilitation New Liquid and other traditional Chinese medicine products, attracting attention from attendees worldwide [3] Group 2 - Good Doctor Rehabilitation New Liquid is a key achievement in the biopharmaceutical industry chain in Liangshan, featuring innovative characteristics in raw material extraction, production processes, and clinical applications [6] - The company established China's first GAP-certified breeding base for American cockroaches in Liangshan, ensuring standardized supply and enhancing production quality through an intelligent factory with a 98% automation rate and an annual capacity of 20,000 tons for the Rehabilitation New Liquid [6] - Good Doctor Group emphasizes the modernization of traditional Chinese medicine through technological innovation, aiming to contribute significantly to human health and the high-quality development of the biopharmaceutical industry [6][7]